140 related articles for article (PubMed ID: 15749807)
1. Prolonged insulin treatment inhibits GH signaling via STAT3 and STAT1.
Xu J; Ji S; Venable DY; Franklin JL; Messina JL
J Endocrinol; 2005 Mar; 184(3):481-92. PubMed ID: 15749807
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
[TBL] [Abstract][Full Text] [Related]
3. Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin.
Gunaje JJ; Bhat GJ
Biochem Biophys Res Commun; 2001 Oct; 288(1):252-7. PubMed ID: 11594781
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
Fang P; Hwa V; Rosenfeld RG
Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between growth hormone and insulin signaling.
Xu J; Messina JL
Vitam Horm; 2009; 80():125-53. PubMed ID: 19251037
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone increases Stat5 and Stat1 expression in lactating goat mammary gland: a specific effect compared to milking frequency.
Boutinaud M; Jammes H
Domest Anim Endocrinol; 2004 Nov; 27(4):363-78. PubMed ID: 15519040
[TBL] [Abstract][Full Text] [Related]
7. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6.
Galdiero M; Vitiello M; D'Isanto M; Raieta K; Galdiero E
Cytokine; 2006 Dec; 36(5-6):218-28. PubMed ID: 17258468
[TBL] [Abstract][Full Text] [Related]
8. [Effect of nocodazole on the activation of transcription factors STAT1 and STAT3 in A431 cells].
Vasilenko KP; Burova EB; Vinogradova NA; Nikol'skiĭ NN
Tsitologiia; 2004; 46(12):1025-9. PubMed ID: 15747831
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3.
Meyer T; Gavenis K; Vinkemeier U
Exp Cell Res; 2002 Jan; 272(1):45-55. PubMed ID: 11740864
[TBL] [Abstract][Full Text] [Related]
10. Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK.
Lo RK; Wise H; Wong YH
Cell Signal; 2006 Mar; 18(3):307-17. PubMed ID: 15979846
[TBL] [Abstract][Full Text] [Related]
11. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
[TBL] [Abstract][Full Text] [Related]
12. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
[TBL] [Abstract][Full Text] [Related]
13. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1.
Lui VW; Boehm AL; Koppikar P; Leeman RJ; Johnson D; Ogagan M; Childs E; Freilino M; Grandis JR
Mol Pharmacol; 2007 May; 71(5):1435-43. PubMed ID: 17325127
[TBL] [Abstract][Full Text] [Related]
15. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
Lo RK; Wong YH
Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
[TBL] [Abstract][Full Text] [Related]
17. EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3.
Grudinkin PS; Zenin VV; Kropotov AV; Dorosh VN; Nikolsky NN
Eur J Cell Biol; 2007 Oct; 86(10):591-603. PubMed ID: 17646016
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of unphosphorylated STAT3 core fragment.
Ren Z; Mao X; Mertens C; Krishnaraj R; Qin J; Mandal PK; Romanowski MJ; McMurray JS; Chen X
Biochem Biophys Res Commun; 2008 Sep; 374(1):1-5. PubMed ID: 18433722
[TBL] [Abstract][Full Text] [Related]
19. Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J.
Robinson K; Vona-Davis L; Riggs D; Jackson B; McFadden D
J Am Coll Surg; 2006 May; 202(5):788-96. PubMed ID: 16648019
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway.
Miranda MB; Xu H; Torchia JA; Johnson DE
Leuk Res; 2005 Nov; 29(11):1293-306. PubMed ID: 16164983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]